Author

Kateland Tiller

Virginia TechORCID 0009-0009-6238-1762Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1 Organism:plant (other)· 1 Assay:proteomics· 1

Frequent Co-Authors

James Weger‐LucarelliiD· 2 shared Anastazja M KiselkaiD· 1 shared Andrew N. LowelliD· 1 shared Anne M. BrowniD· 1 shared Bo WangiD· 1 shared Cole GannettiD· 1 shared Debin TianiD· 1 shared Katherine R. Fike· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

James Weger‐LucarelliORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyACS Infectious DiseasesPeer-reviewedAug 1, 2026

Development of semisynthetic blasticidin S analogs with potent and fast-killing anti-malarial activity

Katherine R. Fike, Cole Gannett, Anastazja M Kiselka…·Michael Klemba

This study develops semisynthetic blasticidin S analogs with higher anti-malarial potency and selectivity than the natural product.

DOI 10.1021/acsinfecdis.6c00362

plant (other)proteomics

𝕏 PostBluesky

MicrobiologybioRxivPreprintMay 2, 2025

Auranofin Inhibits Hepatitis E Virus Replication Via Reactive Oxygen Species

Kateland Tiller, S. Tyler Williams, Bo Wang…·James Weger‐Lucarelli

This paper identifies auranofin as an effective in vitro inhibitor of HEV, showing antiviral activity against multiple genotypes and a ribavirin-resistant mutant, with ROS-mediated mechanism.

DOI 10.1101/2025.05.02.651833

humanexperimental assay

𝕏 PostBluesky